Improving care for unborn and newborn babies with heart defects
Part of Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This study looks at how to improve care for babies with serious heart defects, both before and after birth. It brings together pregnancy and newborn care to help identify and treat these heart problems as early as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- For newborns: diagnosed with a critical heart defect (present at birth), and born at 37 weeks or later.
- For pregnant women: between 18 and 36 weeks of pregnancy, carrying one baby, and referred for a fetal heart ultrasound due to a suspected heart problem.
- The heart problem must be serious enough to need treatment—if it's mild and doesn't need intervention, you can't join.
- You must be willing to stay in contact and have complete medical records.
- Parental or your own written consent is required.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows pregnant women who have congenital heart disease (a heart problem present from birth). The goal is to monitor how both mother and baby are doing, which can help improve care for others in the same situation.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This study looks at how a mother's mental health during pregnancy may affect the brain development of babies with a serious heart condition called critical cyanotic congenital heart disease (CHD). It aims to understand this link to improve support for families.
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This study checks unborn babies’ heart signals using special scans during pregnancy and then checks the baby’s heart shortly after birth. It may help researchers understand why certain high-risk pregnancies can lead to fetal demise and improve care.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.